T he antimicrobial activity of phagocytes depends in part on the cells' ability to reduce oxygen to reactive microbicidal oxidants by means of an NADPH oxidase. In resting phagocytes, the NADPH oxidase is in a dormant state, but exposure of the cell to any of a variety of stimuli can activate the enzyme, causing it to release large amounts of O 2 Ϫ by reducing oxygen at the expense of NADPH. The oxidase is activated by the phosphorylation of one of its cytosolic subunits, p47 PHOX , on particular serines (1). In whole cells, the stimulation of an appropriate receptor activates PKC and phosphatidylinositol 3-kinase (PI3-kinase) (2-4). Although NADPH oxidase activation by PKC has been well characterized (5, 6), the association between PI3-kinase and NADPH oxidase activation remains to be established. A possible connection is through the activation of Akt (7), whose role in oxidase activation is suggested by the finding that Akt is activated rapidly when neutrophils are treated with oxidase-activating agents (8) and by the finding that oxidase activation is inhibited by wortmannin (9). The experiments described here show that Akt is able to activate the oxidase by phosphorylating p47 PHOX on serines S304 and S328.
T he antimicrobial activity of phagocytes depends in part on the cells' ability to reduce oxygen to reactive microbicidal oxidants by means of an NADPH oxidase. In resting phagocytes, the NADPH oxidase is in a dormant state, but exposure of the cell to any of a variety of stimuli can activate the enzyme, causing it to release large amounts of O 2 Ϫ by reducing oxygen at the expense of NADPH. The oxidase is activated by the phosphorylation of one of its cytosolic subunits, p47 PHOX , on particular serines (1) . In whole cells, the stimulation of an appropriate receptor activates PKC and phosphatidylinositol 3-kinase (PI3-kinase) (2) (3) (4) . Although NADPH oxidase activation by PKC has been well characterized (5, 6) , the association between PI3-kinase and NADPH oxidase activation remains to be established. A possible connection is through the activation of Akt (7), whose role in oxidase activation is suggested by the finding that Akt is activated rapidly when neutrophils are treated with oxidase-activating agents (8) and by the finding that oxidase activation is inhibited by wortmannin (9) . The experiments described here show that Akt is able to activate the oxidase by phosphorylating p47 PHOX on serines S304 and S328.
Experimental Procedures
Materials. Active Akt was obtained from Upstate Biotechnology (Lake Placid, NY) or from J.-H.L., whose recombinant material was 95% pure by SDS͞PAGE. [␥-32 P]ATP was purchased from New England Nuclear. Phosphorylated peptides were obtained from Sigma.
Isolation and Fractionation of Neutrophils. Neutrophils were obtained from normal subjects by dextran sedimentation and Ficoll͞Hypaque fractionation of freshly drawn citrateanticoagulated blood (10) . After treatment on ice for 10-20 min with 5 l of 0.54 M diisopropyl fluorophosphate, the neutrophils, suspended at 10 8 cells per ml in a modified relaxation buffer (0.1 M KCl͞3 mM NaCl͞3.5 mM MgCl 2 ͞10 mM Pipes buffer, pH 7.3), were subjected to nitrogen cavitation. Membranes and cytosol were separated by centrifugation through a Percoll gradient. Aliquots of membrane and cytosol were stored at Ϫ70°C until use.
Recombinant Oxidase Components. Recombinant fusion proteins composed of an upstream GST linked to a downstream p47 PHOX , p67 PHOX , or Rac2 were isolated from Escherichia coli transformed with pGEX-6P3 plasmids containing cDNA inserts encoding the downstream proteins. The fusion proteins were isolated by the addition of a prewashed 50% slurry of glutathione-Sepharose 4B (Amersham Biosciences) in PBS (133 mM NaCl͞16 mM Na 2 HPO 4 ͞2.7 mM KCl͞1.5 mM KH 2 PO 4 , pH 7.3). The tube was rotated end-over-end for 1 h at 4°C and then microcentrifuged for 3 min at 200 ϫ g to sediment the glutathione-Sepharose beads. The beads were washed four times with 10 bead volumes of PBS, and the bound fusion proteins were eluted by incubating for 30 min at 4°C with three 1-ml washes of 50 mM Tris⅐HCl, pH 8.0͞20 mM glutathione͞0.2 M NaCl. Excess glutathione was removed from the purified recombinant protein by dialysis against relaxation buffer and concentrated with 10K Biomax Centrifugal Filter devices (Millipore). The concentration of protein was determined with the Bio-Rad Assay Kit, by using BSA as the standard. WT vector was prepared by using the GeneEditor kit (Promega). The mutant constructs S304A, S328A, and S304A͞ S328A were generated following the manufacturer's instructions and using the following oligonucleotides: S304A, GGCACCGC-CCCGCAGGTCGGCCATCCG; and S328A, CCTATCGCCG-GAATGCCGTCCG. The sequence of all mutant constructs was confirmed by dideoxynucleotide-based sequencing.
In Vitro Phosphorylation of GST-p47 PHOX . Labeling with Akt was performed by incubating a reaction mixture of 50 g of GSTp47 PHOX , 1 mM ATP, 10 mM magnesium, and 0.1 g of His-c-Akt (11) or 0.1 unit of Akt in relaxation buffer (pH 7.3) for 30 min at 30°C. The reaction was terminated by the addition of a prewashed 50% slurry of glutathione-Sepharose and isolated as described above. The eluted fusion protein was dialyzed against relaxation buffer before use. To determine the locations of the phosphates in p47 For cell-free assays requiring the removal of ATP, the membranes, cytosol, and prephosphorylated p47 PHOX were processed as described below and run in the assay as described previously, with the exception that ATP was not added. To remove the ATP from the membranes, 100 l of membranes was layered over 2.8 ml of 20% sucrose, which, in turn, was layered over 0.2 ml of 50% sucrose in a 3.5-ml ultracentrifuge tube and spun at 100,000 ϫ g for 30 min at 4°C. The sucrose solution above the floating membrane band was discarded and the floating band was saved. The cytosol and prephosphorylated p47 PHOX were desalted by using a 3000 MWCO Microcon Centrifugal Filter Device (Millipore), and the protein concentration was recalculated by using the Bio-Rad Protein Assay.
Cytosol-containing, cell-free assays free of ATP contained 5 ϫ 10 6 cell equivalents of membrane that had been incubated for 30 min at 30°with 50 M guanosine 5Ј-[␥-thio]triphosphate, 1 g BSA, and 250 nM calyculin, but no ATP. The incubated membranes then were combined with 10 7 cell equivalents of cytosol, 0.1 mM cytochrome c, and 3.0 g of p47
PHOX
, unphosphorylated or phosphorylated with Akt. For sets of cell-free assays requiring the elimination of ATP and the substitution of cytosol for the three cytosolic components, 3 g of p47
(prephosphorylated or unphosphorylated), 6 g of p67
, and 2 g of Rac2 were incubated with ATP-free membranes, 50 mM guanosine 5Ј-[␥-thio]triphosphate, and 250 nM calyculin for 10 min at 30°C and then added to relaxation buffer. Reactions were started with 0.16 mM NADPH and assayed as described above.
Tryptic Phosphopeptide Analysis. Labeled GST-p47 PHOX was detected by autoradiography. The band corresponding to GSTp47 PHOX was cleaved chemically with 50 mg͞ml CNBr in 70% formic acid for 90 min at room temperature or digested three times with 10 g of trypsin in 50 mM ammonium bicarbonate (pH 8) for 2 h at 37°C each. The resulting peptides were separated by SDS͞PAGE or HPLC. For HPLC, the digest was loaded onto a 25-cm analytical C-18 reverse-phase column equilibrated with 0.6% trifluoroacetic acid in water. The column was eluted at 1.5 ml͞min with a linear water-acetonitrile gradient, beginning with 5% acetonitrile͞aqueous trifluoroacetic acid (0.06%) and ending 60 min later with 95% acetonitrile͞ aqueous trifluoroacetic acid (0.054%). Fractions of 0.375 ml were collected, and 32 P-labeled phosphopeptides were detected by Č erenkov counting. Where indicated, phosphopeptides were separated by high-voltage electrophoresis and chromatography on a cellulose thin-layer plate as described by van der Geer and colleagues (12) and were detected by exposing the thin-layer plates to film at Ϫ70°C with an intensifying screen. Phosphopeptides were identified by coelution on reverse-phase liquid chromatography or by colocalization on phosphopeptide maps, using phosphorylated peptide standards purchased from Sigma.
Modification of the Phosphorylation Sites on p47 PHOX During the
Cell-Free Assay. For these experiments, modified cell-free assays using 32 P-labeled GST-p47 PHOX were performed, and aliquots taken from the assays were run on a 10% Bis-Tris gel (NOVEX, San Diego) and exposed to film overnight. In this experiment, the cell-free assay was scaled down to . The identical mobilities of the phosphopeptides indicate that the Cterminal region of the protein (residues 279 -390) is phosphorylated (13, 14, 16) . Fig. 2 . Detection of p47 PHOX tryptic peptides phosphorylated by Akt. Onetenth of a unit of Akt was used to phosphorylate 100 g of p47 PHOX with 2 Ci [ 32 P]ATP. The phosphorylated p47 PHOX was digested with trypsin as described (5) . In some experiments, the phosphopeptides initially were purified by reverse-phase HPLC and then comapped with authentic phosphopeptide standards. For purposes of identification, the lower spot is peptide 1 (per HPLC elution) and the upper spot is peptide 2.
in Fig. 4 . The assays were run for 5 min, followed by the addition of 5ϫ sample buffer to a 20-l (1 g of p47
PHOX
) sample taken from the assay, and heated immediately at 70°C for 10 min before loading onto the gel.
In a separate experiment, 5 g of 32 P-labeled GST-p47 PHOX and 5 g of unphosphorylated p47
PHOX that were cut off the glutathione-Sepharose beads by using Prescission Protease (Amersham Biosciences) were added to a similar, scaled-down, Fig. 3 . Identification of tryptic peptides phosphorylated by Akt. 32 P-labeled p47 PHOX tryptic phosphopeptides were separated by HPLC over a C-18 reverse-phase column and were detected by Č erenkov counting. The peptides were identified as peptide 1 and peptide 2 by two-dimensional phosphopeptide mapping. For identification purposes, each peptide was combined with 10 g of the phosphorylated standard peptides for pS328, pS303, pS304, and pS303͞pS304 (see text). The mobilities of the pS303, pS304, and pS303͞pS304 peptides were all different. (A) Peptide 1 coeluted with the standard for pS328 (RNpSVR). (B) Peptide 2 coeluted with the standard for p304 (RSpSIR). For confirmation, each identified standard was mixed with its corresponding labeled peptide, spotted onto a cellulose plate, and subjected to two-dimensional peptide mapping. In both cases, the standard (ninhydrin staining) and the labeled (autoradiography) peptide were superimposable. cell-free assay and incubated for 5 min. Samples were run on a gel as described above. Both gels were stained, dried down, and exposed to autoradiography film at 70°C overnight (Fig. 6) .
Results
To determine whether Akt-directed phosphorylation of p47 PHOX could be partly responsible for the observed increase in NADPH oxidase activity associated with PI3-kinase activation, we first examined whether Akt was able to phosphorylate p47 PHOX at all. Previous studies using PKC showed that the phosphorylation of serines in the C-terminal quarter of p47 PHOX was an important determinant of the activity of the NADPH oxidase (13-15) . To ascertain whether a similar situation occurred with Akt, we phosphorylated p47 PHOX with a constitutively active mutant of Akt and analyzed the CNBr cleavage products of the phosphorylated protein by SDS͞ PAGE. The results (Fig. 1) showed that, like PKC (lane 2), Akt (lane 1) phosphorylates hydroxyamino acids in the C-terminal quarter of p47 PHOX . Two-dimensional phosphopeptide mapping showed that, unlike PKC, which targets multiple serines in the C-terminal portion of p47 PHOX (17, 18) , Akt-directed phosphorylation was limited chief ly to two tryptic peptides (Fig. 2) . The specific serines phosphorylated by Akt initially were identified by a comparison with earlier peptide maps (5) and by the substrate consensus sequence BXXS͞T, where B is a basic amino acid and X represents any amino acid. These considerations initially directed us to look at the two tryptic phosphopeptides containing S328 and S303͞S304. For these experiments, p47
PHOX first was labeled with [␥-32 P]ATP by Akt. The tryptic peptides then were isolated by reverse-phase HPLC and mapped separately to identify the eluted peptides with the spots on the map shown in Fig. 3 (where peptide 1 corresponded to the lower spot and peptide 2 corresponded to the upper spot). Results obtained by using reversephase HPLC and tryptic phosphopeptide mapping with synthetic tr yptic phosphopeptide standards for serine S328 (RNpSVR)** and serines S303͞S304 (RpSpSIR, pSSIR, RSpSIR) showed that peptide 1 coeluted with the synthetic tryptic peptide containing phosphoserine S328 (Fig. 3A) and peptide 2 coeluted with the synthetic tryptic peptide containing phosphoserine S304 (Fig. 3B) . In a second experiment, mixtures of radiolabeled peptide and the corresponding synthetic peptide were subjected to tryptic peptide mapping as described above. The ninhydrin-visualized spots corresponding to the peptides RSpSIR (containing serine S304) and RNpSVR (containing serine S328) exactly coincided with the autoradiographically visualized spots corresponding to the eluted radioactive peptides 1 and 2, respectively (data not shown). This confirmed S304 and S328 of p47 PHOX as targets for phosphorylation by Akt. Further confirmation of the identities of the peptides was obtained by mapping the S304 and S328 mutants of phosphorylated p47
PHOX
. These results again established that peptide 1 was S328 and peptide 2 was S304 (data not shown).
To investigate whether p47 PHOX phosphorylated by Akt was capable of supporting NADPH oxidase activity by using a cell-free system, we examined O 2
•Ϫ production by the cytochrome c assay, using recombinant p47 (Fig. 4) . These findings confirm S304 and S328 as the functional targets of Akt in the phosphorylation of p47 PHOX . Two potential problems arise. The first is the possibility that the phosphorylation is due to kinases brought into the assay mixtures by the unfractionated cytosol and͞or membranes used in these experiments. The second, less likely, is that sites of phosphorylation may change during the incubation. To rule out the former possibility, oxidase activity was measured after removal of ATP from the reagents. This was accomplished by using desalted cytosol, membranes, and phosphorylated p47 PHOX . The results (Fig. 5A) indicate that phosphorylation is accomplished by Akt, not by kinases fortuitously included in the assay mixtures. In a set of similar assays, recombinant p47 PHOX , p67 PHOX , and Rac2 were used instead of cytosol, resulting in similar activity levels (Fig. 5B) . Finally, 5 g of 32 P-labeled GST-p47 PHOX and 5 g of unphosphorylated Prescission
Protease-cut p47 PHOX were added to a 1 ⁄5-scale cell-free assay and incubated for 5 min. A 20-l aliquot then was taken, added to 5 l of 5ϫ sample buffer, and heated to 70°C for 10 min. The sample then was run on a 10% Bis-Tris gel, stained, dried, and exposed to film overnight. Samples of 1 g of 32 P-labeled GST-p47 PHOX and 1 g of Prescission Protease-cut p47 PHOX were run as markers. No transfer of phosphates from the 32 P-labeled GST-p47 PHOX to the Prescission Protease-cut p47 PHOX occurred (Fig. 6 ).
Discussion
We show here that Akt phosphorylates p47 PHOX on S304 and S328 and that this phosphorylation supports NADPH oxidase activity. We previously have explored the manipulation of several serines identified as targets for phosphorylation during NADPH oxidase activation (19, 20) , and, with the current findings, it will be important to explore the functional role of S304 and S328 further.
Another example of the importance of site-directed phosphorylation in the C terminus of p47 PHOX is the recent observation characterizing the priming effect of granulocyte͞ macrophage colony-stimulating factor on whole neutrophils (21) , where phosphorylation of a single tryptic peptide (not identified) does not act to support oxidase activation but greatly enhances the phosphorylation of p47 PHOX and NADPH oxidase activity after stimulation with N-formyl-methionyl-leucylphenylalanine. Given that the activation of PI3-kinase results in Akt activation and NADPH oxidase activation, our demonstration here that NADPH oxidase is activated by the Akt-mediated phosphorylation of p47 PHOX may explain these results.
In an earlier study in which phorbol myristate acetate, an activator of PKC, was used to stimulate the neutrophils, we found that phosphorylation of one of the pairs (S303, S304) together with another of the pairs (S359, S370) was necessary for oxidase activation (19, 20) . PKC did not phosphorylate S328. In contrast, Akt phosphorylates S304 and S328. We believe that the phosphorylation of S328 by Akt but not by PKC explains why phosphorylation of S359 or S370 is not required for oxidase activation by Akt.
